Second-generation antipsychotics and metabolic side-effects: Canadian population-based study

BACKGROUND: Use of second-generation antipsychotics (SGA) has increased in recent years; however, their use and effect on metabolic outcomes has been poorly characterised in population-level studies. AIMS: This study aimed to determine the associations between SGA use and metabolic indicators in a g...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirsch, Lauren, Patten, Scott B., Bresee, Lauren, Jette, Nathalie, Pringsheim, Tamara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2018
Materias:
Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060488/
https://www.ncbi.nlm.nih.gov/pubmed/29998821
http://dx.doi.org/10.1192/bjo.2018.33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060488/
https://www.ncbi.nlm.nih.gov/pubmed/29998821
http://dx.doi.org/10.1192/bjo.2018.33

Ejemplares similares